Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Scienture Holdings Inc SCNX

Consumer Defensive Pharmaceutical Retailers
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products... see more

Current News (NDAQ:SCNX)

SCIENTURE Provides Update on the Commercial Launch of REZENOPY®, the Highest Strength Naloxone HCl Life-Saving Opioid Overdose Emergency Treatment Approved by the FDA

GlobeNewswire December 22, 2025

SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli(TM), the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium

GlobeNewswire December 10, 2025

SCIENTURE to Participate in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9-10, 2025

GlobeNewswire December 2, 2025

SCIENTURE Reports Q3 2025 Financial Results and Provides Business Update

GlobeNewswire November 13, 2025

SCIENTURE Announces Addition of Arbli(TM) (Losartan Potassium) to Formularies of Major National Health Plans

GlobeNewswire November 4, 2025

SCIENTURE Announces Start of Commercial Sales and Fulfillment of First Orders for Arbli(TM) (Losartan Potassium)

GlobeNewswire October 23, 2025

SCIENTURE'S Arbli(TM) Becomes First FDA-Approved Ready-to-Use Liquid Losartan Available Through Major U.S. Wholesalers

GlobeNewswire October 16, 2025

SCIENTURE Holdings Announces Full Repayment and Conversion of Outstanding Debentures, Strengthening Balance Sheet

GlobeNewswire October 8, 2025

SCIENTURE Secures Multiple Commercial GPO Agreements, Expanding U.S. Market Access for Arbli(TM) (losartan potassium) to more than 2500 Healthcare Institutions

GlobeNewswire October 1, 2025
View More News ››

Opinion & Analysis (NDAQ:SCNX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SCNX)

SCNX.... 5 days later it tapped N.L.O.D....54 cents ; )

54 cents
Iseneschal - December 15, 2025

SCNX...a.m NR... Last Mtgthey voted on RS....Hmmm!

Here is the SEC link to the results: https://www.sec.gov/Archives/edgar/data/1382574/000149315225023614/form8-k.htm You be the judge......
Iseneschal - December 10, 2025

Using technical analysis for this stock.

It is signalling a continuing downtrend for shareholders today,so good luck to all of you 
coolfooldumbguy - October 27, 2025

Sell buddy sell.

Otherwise you guys out there will be losing your money with this stock today
coolfooldumbguy - October 24, 2025

Buy buddy buy.

Otherwise you guys out there will be left behind by the markets and
coolfooldumbguy - March 18, 2025

Buy buddy buy because it's taking off this morning.

Otherwise you guys will be missing out on this stock today and making big profits also good luck to all of you guys out there and to buy...
coolfooldumbguy - March 6, 2025
View more Bullboard ››

Pelangio Exploration Inc.

Pelangio Exploration Inc.

Pelangio Exploration Inc., a mineral exploration company, engages in the acquisition, exploration, and development of mineral ...
View More »

Podcasts